← Library
Sold as a supplement, not an FDA-approved drug. This page is educational information only, not medical advice.
IndexedBuilt automatically from public databases on 2026-09-30. Not yet hand-reviewed by PLOBT.How this works →

Sardine peptides

Supplement

Food-derived bioactive peptide

Also known as: valyl-tyrosine

Evidence score
29/ 100
Thin evidence

Very thin human evidence

  • Regulatory standing. Sold as a supplement, not an approved drug
  • Limited human data. Some human data exists, not conclusive
  • No registered human trials. Nothing registered on ClinicalTrials.gov
  • No sources. Nothing cited to verify

Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.

What it is

Sardine peptides are short protein fragments produced by enzymatic breakdown of sardine muscle, with valyl-tyrosine (Val-Tyr) often cited as a key component. They are sold as dietary supplement ingredients and are thought to act by mildly inhibiting angiotensin-converting enzyme (ACE), which plays a role in blood pressure regulation.

What the evidence shows

Automatic summaryLimited human data

A small number of human studies, mostly from Japan, have looked at blood pressure effects, but the evidence is limited, with only one registered human trial and few published papers. It is not FDA-approved for any condition, and whether it has meaningful clinical effects remains unclear.

Registered human trials

Live from ClinicalTrials.gov, refreshed daily.

0registered studies
Nonemost advanced phase
0completed (sample)
0recruiting (sample)

Published literature

Sources

Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.